2014 Q4 Form 10-Q Financial Statement

#000153702814000009 Filed on November 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q4
Revenue $23.01M $19.12M $13.14M
YoY Change 75.13% 64.8%
Cost Of Revenue $12.69M $11.91M $8.440M
YoY Change 50.36% 64.5%
Gross Profit $10.33M $7.210M $4.700M
YoY Change 119.79% 64.99%
Gross Profit Margin 44.89% 37.7% 35.77%
Selling, General & Admin $4.440M $3.618M $2.730M
YoY Change 62.64% 72.7%
% of Gross Profit 42.98% 50.18% 58.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.650M $4.210M $3.190M
YoY Change 45.77% 67.73%
% of Gross Profit 45.01% 58.39% 67.87%
Operating Expenses $9.080M $3.618M $5.910M
YoY Change 53.64% 72.7%
Operating Profit -$28.64M -$672.0K -$1.195M
YoY Change 2296.65% 178.84%
Interest Expense $2.250M -$1.090M $630.0K
YoY Change 257.14% -430.3%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$26.39M -$1.765M -$570.0K
YoY Change 4529.82% -2128.74%
Income Tax -$1.788M -$352.0K -$360.0K
% Of Pretax Income
Net Earnings -$24.61M -$1.413M -$208.0K
YoY Change 11729.81% -345.31%
Net Earnings / Revenue -106.92% -7.39% -1.58%
Basic Earnings Per Share -$1.00 -$0.07 -$0.02
Diluted Earnings Per Share -$1.00 -$0.07 -$0.02
COMMON SHARES
Basic Shares Outstanding 24.63M shares 19.17M shares
Diluted Shares Outstanding 19.17M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.80M $13.20M $2.700M
YoY Change 300.0%
Cash & Equivalents $10.76M $13.17M $2.730M
Short-Term Investments
Other Short-Term Assets $4.300M $2.900M $8.200M
YoY Change -47.56%
Inventory $2.100M $1.900M $1.100M
Prepaid Expenses
Receivables $19.13M $12.62M $9.089M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $36.30M $30.60M $21.16M
YoY Change 71.57%
LONG-TERM ASSETS
Property, Plant & Equipment $250.5M $222.8M $129.5M
YoY Change 93.45%
Goodwill $0.00 $11.01M $11.01M
YoY Change -100.0%
Intangibles $0.00 $20.30M $22.36M
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $2.749M $1.701M $959.0K
YoY Change 186.65%
Total Long-Term Assets $253.2M $255.8M $163.8M
YoY Change 54.6%
TOTAL ASSETS
Total Short-Term Assets $36.30M $30.60M $21.16M
Total Long-Term Assets $253.2M $255.8M $163.8M
Total Assets $289.5M $286.4M $185.0M
YoY Change 56.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.99M $15.67M $9.061M
YoY Change 142.72%
Accrued Expenses $6.970M $6.210M $4.167M
YoY Change 67.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $22.50M
YoY Change
Total Short-Term Liabilities $51.89M $22.03M $13.53M
YoY Change 283.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $19.80M
YoY Change -100.0%
Other Long-Term Liabilities $600.0K $2.400M $3.200M
YoY Change -81.25%
Total Long-Term Liabilities $600.0K $2.400M $23.00M
YoY Change -97.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $51.89M $22.03M $13.53M
Total Long-Term Liabilities $600.0K $2.400M $23.00M
Total Liabilities $52.81M $26.47M $40.10M
YoY Change 31.71%
SHAREHOLDERS EQUITY
Retained Earnings -$35.29M -$10.68M -$7.121M
YoY Change 395.56%
Common Stock $273.0M $271.6M $152.7M
YoY Change 78.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $971.0K $971.0K $746.0K
YoY Change 30.16%
Treasury Stock Shares 85.01K shares 84.85K shares 85.01K shares
Shareholders Equity $236.7M $260.0M $144.9M
YoY Change
Total Liabilities & Shareholders Equity $289.5M $286.4M $185.0M
YoY Change 56.54%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q4
OPERATING ACTIVITIES
Net Income -$24.61M -$1.413M -$208.0K
YoY Change 11729.81% -345.31%
Depreciation, Depletion And Amortization $4.650M $4.210M $3.190M
YoY Change 45.77% 67.73%
Cash From Operating Activities -$6.750M $7.410M $5.470M
YoY Change -223.4% 915.07%
INVESTING ACTIVITIES
Capital Expenditures -$17.48M -$49.18M -$19.86M
YoY Change -11.98% 391.8%
Acquisitions
YoY Change
Other Investing Activities $160.0K $10.00K $140.0K
YoY Change 14.29%
Cash From Investing Activities -$17.32M -$49.16M -$19.72M
YoY Change -12.17% 392.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.65M 52.05M 14.13M
YoY Change 53.22% 834.47%
NET CHANGE
Cash From Operating Activities -6.750M 7.410M 5.470M
Cash From Investing Activities -17.32M -49.16M -19.72M
Cash From Financing Activities 21.65M 52.05M 14.13M
Net Change In Cash -2.420M 10.30M -120.0K
YoY Change 1916.67% -379.13%
FREE CASH FLOW
Cash From Operating Activities -$6.750M $7.410M $5.470M
Capital Expenditures -$17.48M -$49.18M -$19.86M
Free Cash Flow $10.73M $56.59M $25.33M
YoY Change -57.64% 427.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6210000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4167000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
15668000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9061000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9089000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12622000 USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
157000 USD
CY2013Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
485000 USD
CY2014Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1169000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4167000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6210000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
271386000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
152615000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2397000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
570000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1638000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1161000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2397000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
508000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
99000 USD
CY2014Q3 us-gaap Assets
Assets
286447000 USD
CY2013Q4 us-gaap Assets
Assets
184968000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
30603000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
21157000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2730000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13173000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37407000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2856000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-34551000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10443000 USD
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.37
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.74
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12464625 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24656859 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24572005 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12397900 shares
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
246000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
124000 USD
us-gaap Costs And Expenses
CostsAndExpenses
51760000 USD
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
19795000 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
11845000 USD
us-gaap Costs And Expenses
CostsAndExpenses
33107000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1570000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1657000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
684000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1174000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
149000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
149000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2022000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3593000 USD
CY2014Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
0 USD
CY2013Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
6168000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
11533000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7002000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7002000 USD
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4216000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11533000 USD
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2511000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
769000 USD
CY2014Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-611000 USD
CY2013Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
351000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
273000 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3189000 USD
CY2014Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2420000 USD
CY2014Q3 us-gaap Direct Operating Costs
DirectOperatingCosts
11909000 USD
us-gaap Direct Operating Costs
DirectOperatingCosts
19963000 USD
us-gaap Direct Operating Costs
DirectOperatingCosts
29969000 USD
CY2013Q3 us-gaap Direct Operating Costs
DirectOperatingCosts
7239000 USD
CY2014Q3 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
52000 USD
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-139000 USD
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-41000 USD
CY2013Q3 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
0 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1868000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1840000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
299000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
397000 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
104000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
184000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5549000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
712000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
0 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-586000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
137000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-165000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
11007000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
11007000 USD
CY2013Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2014Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2612000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1765000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5132000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3309000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1570000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-489000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-352000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1520000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
168000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1003000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
348000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
897000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
465000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3148000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3533000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20304000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22357000 USD
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-482000 USD
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-23000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-120000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1474000 USD
us-gaap Interest Paid
InterestPaid
1741000 USD
us-gaap Interest Paid
InterestPaid
4000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-1413000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-95374000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39551000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
527000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
10564000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3562000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1789000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
576000 USD
CY2013Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1128000 USD
CY2014Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1871000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
26469000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
40096000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
286447000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
184968000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22027000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13534000 USD
CY2013Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
18600000 USD
CY2014Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
CY2013Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
19780000 USD
CY2014Q3 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
77000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4473000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
95253000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Operating Income Loss
OperatingIncomeLoss
-3462000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-241000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-672000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4427000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1363000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
49000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
139000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
327000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
637000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129488000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
222832000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
501000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
50000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
161000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
296000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
343000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1701000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
959000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
225000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1109000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1238000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39826000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
97913000 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2937000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2042000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2038000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
116496000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
104972000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10704000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
275000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
124752000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5122000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10683000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7121000 USD
CY2014Q3 us-gaap Revenues
Revenues
19123000 USD
us-gaap Revenues
Revenues
29645000 USD
CY2013Q3 us-gaap Revenues
Revenues
11604000 USD
us-gaap Revenues
Revenues
47333000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2095000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3618000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7785000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6183000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1339000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
304832 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.74
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
360316 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.63
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
304832 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.63
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
620412 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.00
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.00
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
602880 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
963196 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
963196 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
225000 USD
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
260096 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.55
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
116496000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
144872000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
259978000 USD
CY2014Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.57
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
787000 USD
CY2014Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
1731000 USD
CY2014Q3 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
84854 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
66725 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
84854 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
746000 USD
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
971000 USD
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
76000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12256000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14563000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12179000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19174000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12180000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19174000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12179000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14563000 shares
CY2014Q2 icd Costof Rig Repairs
CostofRigRepairs
2000000 USD
CY2014Q2 icd Out Of Pocket Expense Rig Repair
OutOfPocketExpenseRigRepair
300000 USD
CY2014Q2 icd Proceeds From Insurance Settlements Gross
ProceedsFromInsuranceSettlementsGross
2300000 USD
icd Proceeds From Insurance Settlements Gross
ProceedsFromInsuranceSettlementsGross
2300000 USD
icd Purchasesof Property Plantand Equipmentin Accounts Payable
PurchasesofPropertyPlantandEquipmentinAccountsPayable
4682000 USD
icd Purchasesof Property Plantand Equipmentin Accounts Payable
PurchasesofPropertyPlantandEquipmentinAccountsPayable
7069000 USD
icd Vendor Advances
VendorAdvances
1627000 USD
icd Vendor Advances
VendorAdvances
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001537028
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24629490 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Independence Contract Drilling, Inc.

Files In Submission

Name View Source Status
0001537028-14-000009-index-headers.html Edgar Link pending
0001537028-14-000009-index.html Edgar Link pending
0001537028-14-000009.txt Edgar Link pending
0001537028-14-000009-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icd-20140930.xml Edgar Link completed
icd-20140930.xsd Edgar Link pending
icd-20140930x10q.htm Edgar Link pending
icd-20140930x10qexx311.htm Edgar Link pending
icd-20140930x10qexx312.htm Edgar Link pending
icd-20140930x10qexx321.htm Edgar Link pending
icd-20140930x10qexx322.htm Edgar Link pending
icd-20140930_cal.xml Edgar Link unprocessable
icd-20140930_def.xml Edgar Link unprocessable
icd-20140930_lab.xml Edgar Link unprocessable
icd-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending